Plasma cholesterol and risk for late-onset Alzheimer's disease

Expert Review of Neurotherapeutics

Volumn 11, Issue 4, 2011, Pages 495-498

  Cedazo Mínguez, Angel ^a   Ismail, Muhammad Al Mustafa ^a   Mateos, Laura ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; cholesterol; cognitive decline; late onset; risk factors

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; DEPTH PERCEPTION; DISEASE COURSE; FOLLOW UP; HUMAN; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; RISK FACTOR; THINKING;

EID: 79953733579     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.36     Document Type: Article

References (24)

1. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc. Health Risk Manag. 4(2), 363-381 (2008). (Pubitemid 351711965)
2. Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry 16(5), 343-354 (2008).
3. Panza F, D'Introno A, Colacicco AM et al. Lipid metabolism in cognitive decline and dementia. Brain Res. Rev. 51(2), 275-292 (2006). (Pubitemid 44183829)
4. Hartmann T, Kuchenbecker J, Grimm MO. Alzheimer's disease: the lipid connection. J. Neurochem. 103(Suppl. 1), 159-170 (2007).
5. Kivipelto M, Solomon A. Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence. Acta Neurol. Scand. Suppl. 185, 50-57 (2006). (Pubitemid 44015225)
6. Kalmijn S, Foley D, White L et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler. Thromb. Vasc. Biol. 20(10), 2255-2260 (2000).
7. Cedazo-Minguez A. Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. J. Cell. Mol. Med. 11(6), 1227-1238 (2007).
8. Jones L, Harold D, Williams J. Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease. Biochim. Biophys. Acta 1801(8), 754-761 (2010).
9. Kivipelto M, Rovio S, Ngandu T et al. Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study. J. Cell. Mol. Med. 12(6B), 2762-2771, (2008).
10. Solomon A, Kivipelto M. Cholesterol-modifying strategies for Alzheimer's disease. Expert Rev. Neurother. 9(5), 695-709 (2009).
11. Hirsch-Reinshagen V, Burgess BL, Wellington CL. Why lipids are important for Alzheimer disease? Mol. Cell. Biochem. 326(1-2), 121-129 (2009).
12. Kandiah N, Feldman HH. Therapeutic potential of statins in Alzheimer's disease. J. Neurol. Sci. 283(1-2), 230-234 (2009).
13. Altman R, Rutledge JC. The vascular contribution to Alzheimer's disease. Clin. Sci. (Lond.) 119(10), 407-421 (2010).
14. Zlokovic BV. New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics 5(3), 409-414 (2008). (Pubitemid 351952489)
15. Famer D, Meaney S, Mousavi M, Nordberg A, Bjorkhem I, Crisby M. Regulation of α- and β-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the a-secretase pathway. Biochem. Biophys. Res. Commun. 359(1), 46-50 (2007). (Pubitemid 46844819)
16. Bjorkhem I, Cedazo-Minguez A, Leoni V, Meaney S. Oxysterols and neurodegenerative diseases. Mol. Aspects Med. 30(3), 171-179 (2009).
17. Mateos L, Akterin S, Gil-Bea FJ et al. Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro. Brain Pathol. 19(1), 69-80 (2009).
18. Ullrich C, Pirchl M, Humpel C. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol. Cell. Neurosci. 45(4), 408-417 (2010).
19. Mateos L, Ismail MAM, Gil-Bea FJ et al. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease. J. Alzheimers Dis. DOI: 10.3233/JAD-2011-101512 (2011) (Epub ahead of print).
20. Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch. Neurol. 61(5), 705-714 (2004). (Pubitemid 38637688)
21. Elias PK, Elias MF, D'Agostino RB, Sullivan LM, Wolf PA. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom. Med. 67(1), 24-30 (2005).
22. Reitz C, Tang MX, Schupf N et al. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch. Neurol. 67 (12), 1491-1497 (2010).
23. Morley JE, Banks WA. Lipids and cognition. J. Alzheimers Dis 20(3), 737-747 (2010).
24. Ferrannini E, Gastaldelli A, Iozzo P. Pathophysiology of prediabetes. Med. Clin. North Am. 95(2), 327-339 (2011).